APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lenalidomide

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone.

Selected research

Market Analysis & Forecast

Global Lenalidomide Market Analysis and Forecast 2026-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchLenalidomide Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Lenalidomide Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Lenalidomide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lenalidomide Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lenalidomide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone.

In China, Lenalidomide key players include Celgene, SL Pharma.

In terms of product, 25 mg Capsules is the largest segment, with a share over 40%. And in terms of application, the largest application is Multiple myeloma (MM), followed by Myelodysplastic syndromes (MDS).

Read the full market overview

This report presents an overview of global market for Lenalidomide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lenalidomide, also provides the sales of main regions and countries. Of the upcoming market potential for Lenalidomide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lenalidomide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lenalidomide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lenalidomide sales, projected growth trends, production technology, application and end-user industry.

Lenalidomide Segment by Company

Celgene

SL Pharma

Lenalidomide Segment by Type

5 mg Capsules

10 mg Capsules

15 mg Capsules

25 mg Capsules

Lenalidomide Segment by Application

Multiple myeloma (MM)

Myelodysplastic syndromes (MDS)

Lenalidomide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lenalidomide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lenalidomide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lenalidomide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lenalidomide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lenalidomide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lenalidomide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lenalidomide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5 mg Capsules Major Manufacturers Table 3. 10 mg Capsules Major Manufacturers Table 4. 15 mg Capsules Major Manufacturers Table 5. 25 mg Capsules Major Manufacturers Table 6. Global Lenalidomide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Multiple myeloma (MM) Major Manufacturers Table 8. Myelodysplastic syndromes (MDS) Major Manufacturers Table 9. Lenalidomide Industry Trends Table 10. Lenalidomide Industry Drivers Table 11. Lenalidomide Industry Opportunities and Challenges Table 12. Lenalidomide Industry Restraints Table 13. Global Lenalidomide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Lenalidomide Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Lenalidomide Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Lenalidomide Revenue Market Share by Region (2021-2026) Table 17. Global Lenalidomide Revenue Market Share by Region (2027-2032) Table 18. Global Lenalidomide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 19. Global Lenalidomide Sales by Region (2021-2026) & (K Pcs) Table 20. Global Lenalidomide Sales by Region (2027-2032) & (K Pcs) Table 21. Global Lenalidomide Sales Market Share by Region (2021-2026) Table 22. Global Lenalidomide Sales Market Share by Region (2027-2032) Table 23. Global Lenalidomide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Lenalidomide Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Lenalidomide Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Lenalidomide Sales Market Share by Manufacturers (2021-2026) Table 27. Global Lenalidomide Sales Price (USD/Pcs) of Manufacturers (2021-2026) Table 28. Global Lenalidomide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Lenalidomide Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Lenalidomide Manufacturers, Product Type & Application Table 31. Global Lenalidomide Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Lenalidomide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Lenalidomide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Lenalidomide Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Lenalidomide Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Lenalidomide Revenue Market Share by Type (2021-2026) Table 38. Global Lenalidomide Revenue Market Share by Type (2027-2032) Table 39. Global Lenalidomide Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 40. Global Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 41. Global Lenalidomide Sales by Type (2027-2032) & (K Pcs) Table 42. Global Lenalidomide Sales Market Share by Type (2021-2026) Table 43. Global Lenalidomide Sales Market Share by Type (2027-2032) Table 44. Global Lenalidomide Price by Type (2021-2026) & (USD/Pcs) Table 45. Global Lenalidomide Price by Type (2027-2032) & (USD/Pcs) Table 46. Global Lenalidomide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Lenalidomide Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Lenalidomide Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Lenalidomide Revenue Market Share by Application (2021-2026) Table 50. Global Lenalidomide Revenue Market Share by Application (2027-2032) Table 51. Global Lenalidomide Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 52. Global Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 53. Global Lenalidomide Sales by Application (2027-2032) & (K Pcs) Table 54. Global Lenalidomide Sales Market Share by Application (2021-2026) Table 55. Global Lenalidomide Sales Market Share by Application (2027-2032) Table 56. Global Lenalidomide Price by Application (2021-2026) & (USD/Pcs) Table 57. Global Lenalidomide Price by Application (2027-2032) & (USD/Pcs) Table 58. Celgene Company Information Table 59. Celgene Business Overview Table 60. Celgene Lenalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 61. Celgene Lenalidomide Product Portfolio Table 62. Celgene Recent Development Table 63. SL Pharma Company Information Table 64. SL Pharma Business Overview Table 65. SL Pharma Lenalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 66. SL Pharma Lenalidomide Product Portfolio Table 67. SL Pharma Recent Development Table 68. North America Lenalidomide Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Lenalidomide Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 71. North America Lenalidomide Sales by Type (2027-2032) & (K Pcs) Table 72. North America Lenalidomide Sales Price by Type (2021-2026) & (USD/Pcs) Table 73. North America Lenalidomide Sales Price by Type (2027-2032) & (USD/Pcs) Table 74. North America Lenalidomide Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Lenalidomide Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 77. North America Lenalidomide Sales by Application (2027-2032) & (K Pcs) Table 78. North America Lenalidomide Sales Price by Application (2021-2026) & (USD/Pcs) Table 79. North America Lenalidomide Sales Price by Application (2027-2032) & (USD/Pcs) Table 80. North America Lenalidomide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Lenalidomide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Lenalidomide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Lenalidomide Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 84. North America Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 85. North America Lenalidomide Sales by Country (2027-2032) & (K Pcs) Table 86. North America Lenalidomide Sales Price by Country (2021-2026) & (USD/Pcs) Table 87. North America Lenalidomide Sales Price by Country (2027-2032) & (USD/Pcs) Table 88. United States Lenalidomide Revenue (2021-2032) & (US$ Million) Table 89. Canada Lenalidomide Revenue (2021-2032) & (US$ Million) Table 90. Mexico Lenalidomide Revenue (2021-2032) & (US$ Million) Table 91. Europe Lenalidomide Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Lenalidomide Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 94. Europe Lenalidomide Sales by Type (2027-2032) & (K Pcs) Table 95. Europe Lenalidomide Sales Price by Type (2021-2026) & (USD/Pcs) Table 96. Europe Lenalidomide Sales Price by Type (2027-2032) & (USD/Pcs) Table 97. Europe Lenalidomide Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Lenalidomide Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 100. Europe Lenalidomide Sales by Application (2027-2032) & (K Pcs) Table 101. Europe Lenalidomide Sales Price by Application (2021-2026) & (USD/Pcs) Table 102. Europe Lenalidomide Sales Price by Application (2027-2032) & (USD/Pcs) Table 103. Europe Lenalidomide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Lenalidomide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Lenalidomide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Lenalidomide Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 107. Europe Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 108. Europe Lenalidomide Sales by Country (2027-2032) & (K Pcs) Table 109. Europe Lenalidomide Sales Price by Country (2021-2026) & (USD/Pcs) Table 110. Europe Lenalidomide Sales Price by Country (2027-2032) & (USD/Pcs) Table 111. Germany Lenalidomide Revenue (2021-2032) & (US$ Million) Table 112. France Lenalidomide Revenue (2021-2032) & (US$ Million) Table 113. U.K. Lenalidomide Revenue (2021-2032) & (US$ Million) Table 114. Italy Lenalidomide Revenue (2021-2032) & (US$ Million) Table 115. Russia Lenalidomide Revenue (2021-2032) & (US$ Million) Table 116. Spain Lenalidomide Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Lenalidomide Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Lenalidomide Revenue (2021-2032) & (US$ Million) Table 119. Sweden Lenalidomide Revenue (2021-2032) & (US$ Million) Table 120. Poland Lenalidomide Revenue (2021-2032) & (US$ Million) Table 121. China Lenalidomide Revenue by Type (2021-2026) & (US$ Million) Table 122. China Lenalidomide Revenue by Type (2027-2032) & (US$ Million) Table 123. China Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 124. China Lenalidomide Sales by Type (2027-2032) & (K Pcs) Table 125. China Lenalidomide Sales Price by Type (2021-2026) & (USD/Pcs) Table 126. China Lenalidomide Sales Price by Type (2027-2032) & (USD/Pcs) Table 127. China Lenalidomide Revenue by Application (2021-2026) & (US$ Million) Table 128. China Lenalidomide Revenue by Application (2027-2032) & (US$ Million) Table 129. China Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 130. China Lenalidomide Sales by Application (2027-2032) & (K Pcs) Table 131. China Lenalidomide Sales Price by Application (2021-2026) & (USD/Pcs) Table 132. China Lenalidomide Sales Price by Application (2027-2032) & (USD/Pcs) Table 133. Asia Lenalidomide Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Lenalidomide Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 136. Asia Lenalidomide Sales by Type (2027-2032) & (K Pcs) Table 137. Asia Lenalidomide Sales Price by Type (2021-2026) & (USD/Pcs) Table 138. Asia Lenalidomide Sales Price by Type (2027-2032) & (USD/Pcs) Table 139. Asia Lenalidomide Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Lenalidomide Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 142. Asia Lenalidomide Sales by Application (2027-2032) & (K Pcs) Table 143. Asia Lenalidomide Sales Price by Application (2021-2026) & (USD/Pcs) Table 144. Asia Lenalidomide Sales Price by Application (2027-2032) & (USD/Pcs) Table 145. Asia Lenalidomide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Lenalidomide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Lenalidomide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Lenalidomide Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 149. Asia Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 150. Asia Lenalidomide Sales by Country (2027-2032) & (K Pcs) Table 151. Asia Lenalidomide Sales Price by Country (2021-2026) & (USD/Pcs) Table 152. Asia Lenalidomide Sales Price by Country (2027-2032) & (USD/Pcs) Table 153. Japan Lenalidomide Revenue (2021-2032) & (US$ Million) Table 154. South Korea Lenalidomide Revenue (2021-2032) & (US$ Million) Table 155. India Lenalidomide Revenue (2021-2032) & (US$ Million) Table 156. Australia Lenalidomide Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Lenalidomide Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Lenalidomide Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Lenalidomide Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Lenalidomide Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 162. SAMEA Lenalidomide Sales by Type (2027-2032) & (K Pcs) Table 163. SAMEA Lenalidomide Sales Price by Type (2021-2026) & (USD/Pcs) Table 164. SAMEA Lenalidomide Sales Price by Type (2027-2032) & (USD/Pcs) Table 165. SAMEA Lenalidomide Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Lenalidomide Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 168. SAMEA Lenalidomide Sales by Application (2027-2032) & (K Pcs) Table 169. SAMEA Lenalidomide Sales Price by Application (2021-2026) & (USD/Pcs) Table 170. SAMEA Lenalidomide Sales Price by Application (2027-2032) & (USD/Pcs) Table 171. SAMEA Lenalidomide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Lenalidomide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Lenalidomide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Lenalidomide Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 175. SAMEA Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 176. SAMEA Lenalidomide Sales by Country (2027-2032) & (K Pcs) Table 177. SAMEA Lenalidomide Sales Price by Country (2021-2026) & (USD/Pcs) Table 178. SAMEA Lenalidomide Sales Price by Country (2027-2032) & (USD/Pcs) Table 179. Brazil Lenalidomide Revenue (2021-2032) & (US$ Million) Table 180. Argentina Lenalidomide Revenue (2021-2032) & (US$ Million) Table 181. Chile Lenalidomide Revenue (2021-2032) & (US$ Million) Table 182. Colombia Lenalidomide Revenue (2021-2032) & (US$ Million) Table 183. Peru Lenalidomide Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Lenalidomide Revenue (2021-2032) & (US$ Million) Table 185. Israel Lenalidomide Revenue (2021-2032) & (US$ Million) Table 186. UAE Lenalidomide Revenue (2021-2032) & (US$ Million) Table 187. Turkey Lenalidomide Revenue (2021-2032) & (US$ Million) Table 188. Iran Lenalidomide Revenue (2021-2032) & (US$ Million) Table 189. Egypt Lenalidomide Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Lenalidomide Distributors List Table 193. Lenalidomide Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Lenalidomide Image Figure 2. Global Lenalidomide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lenalidomide Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5 mg Capsules Image Figure 5. 10 mg Capsules Image Figure 6. 15 mg Capsules Image Figure 7. 25 mg Capsules Image Figure 8. Global Lenalidomide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Lenalidomide Market Size Share 2021 VS 2025 VS 2032 Figure 10. Multiple myeloma (MM) Image Figure 11. Myelodysplastic syndromes (MDS) Image Figure 12. Global Lenalidomide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Lenalidomide Revenue (2021-2032) & (US$ Million) Figure 14. Global Lenalidomide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Lenalidomide Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Lenalidomide Revenue Market Share by Region (2021-2032) Figure 17. Global Lenalidomide Sales (2021-2032) & (K Pcs) Figure 18. Global Lenalidomide Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 19. Global Lenalidomide Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Lenalidomide Sales YoY (2021-2032) & (K Pcs) Figure 21. Europe Lenalidomide Sales YoY (2021-2032) & (K Pcs) Figure 22. China Lenalidomide Sales YoY (2021-2032) & (K Pcs) Figure 23. Asia (Excluding China) Lenalidomide Sales YoY (2021-2032) & (K Pcs) Figure 24. South America, Middle East and Africa Lenalidomide Sales YoY (2021-2032) & (K Pcs) Figure 25. Global Lenalidomide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Lenalidomide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Lenalidomide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Lenalidomide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Lenalidomide Revenue Market Share by Type (2021-2032) Figure 31. Global Lenalidomide Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 32. Global Lenalidomide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Lenalidomide Sales Market Share by Type (2021-2032) Figure 34. Global Lenalidomide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Lenalidomide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Lenalidomide Revenue Market Share by Application (2021-2032) Figure 37. Global Lenalidomide Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 38. Global Lenalidomide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Lenalidomide Sales Market Share by Application (2021-2032) Figure 40. North America Lenalidomide Revenue Share by Type (2021-2032) Figure 41. North America Lenalidomide Sales Share by Type (2021-2032) Figure 42. North America Lenalidomide Revenue Share by Application (2021-2032) Figure 43. North America Lenalidomide Sales Share by Application (2021-2032) Figure 44. North America Lenalidomide Revenue Share by Country (2021-2032) Figure 45. North America Lenalidomide Sales Share by Country (2021-2032) Figure 46. Europe Lenalidomide Revenue Share by Type (2021-2032) Figure 47. Europe Lenalidomide Sales Share by Type (2021-2032) Figure 48. Europe Lenalidomide Revenue Share by Application (2021-2032) Figure 49. Europe Lenalidomide Sales Share by Application (2021-2032) Figure 50. Europe Lenalidomide Revenue Share by Country (2021-2032) Figure 51. Europe Lenalidomide Sales Share by Country (2021-2032) Figure 52. China Lenalidomide Revenue Share by Type (2021-2032) Figure 53. China Lenalidomide Sales Share by Type (2021-2032) Figure 54. China Lenalidomide Revenue Share by Application (2021-2032) Figure 55. China Lenalidomide Sales Share by Application (2021-2032) Figure 56. Asia Lenalidomide Revenue Share by Type (2021-2032) Figure 57. Asia Lenalidomide Sales Share by Type (2021-2032) Figure 58. Asia Lenalidomide Revenue Share by Application (2021-2032) Figure 59. Asia Lenalidomide Sales Share by Application (2021-2032) Figure 60. Asia Lenalidomide Revenue Share by Country (2021-2032) Figure 61. Asia Lenalidomide Sales Share by Country (2021-2032) Figure 62. SAMEA Lenalidomide Revenue Share by Type (2021-2032) Figure 63. SAMEA Lenalidomide Sales Share by Type (2021-2032) Figure 64. SAMEA Lenalidomide Revenue Share by Application (2021-2032) Figure 65. SAMEA Lenalidomide Sales Share by Application (2021-2032) Figure 66. SAMEA Lenalidomide Revenue Share by Country (2021-2032) Figure 67. SAMEA Lenalidomide Sales Share by Country (2021-2032) Figure 68. Lenalidomide Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Lenalidomide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg Capsules
  • 10 mg Capsules
  • 15 mg Capsules
  • 25 mg Capsules
Applications
  • Multiple myeloma (MM)
  • Myelodysplastic syndromes (MDS)
Companies covered
  • Celgene
  • SL Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lenalidomide Market by Type
  3. 1.2.1 Global Lenalidomide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5 mg Capsules
  5. 1.2.3 10 mg Capsules
  6. 1.2.4 15 mg Capsules
  7. 1.2.5 25 mg Capsules
  8. 1.3 Lenalidomide Market by Application
  9. 1.3.1 Global Lenalidomide Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Multiple myeloma (MM)
  11. 1.3.3 Myelodysplastic syndromes (MDS)
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Lenalidomide Market Dynamics
  1. 2.1 Lenalidomide Industry Trends
  2. 2.2 Lenalidomide Industry Drivers
  3. 2.3 Lenalidomide Industry Opportunities and Challenges
  4. 2.4 Lenalidomide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lenalidomide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lenalidomide Revenue by Region
  3. 3.2.1 Global Lenalidomide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lenalidomide Revenue by Region (2021-2026)
  5. 3.2.3 Global Lenalidomide Revenue by Region (2027-2032)
  6. 3.2.4 Global Lenalidomide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lenalidomide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lenalidomide Sales by Region
  9. 3.4.1 Global Lenalidomide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lenalidomide Sales by Region (2021-2026)
  11. 3.4.3 Global Lenalidomide Sales by Region (2027-2032)
  12. 3.4.4 Global Lenalidomide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lenalidomide Revenue by Manufacturers
  2. 4.1.1 Global Lenalidomide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lenalidomide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lenalidomide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lenalidomide Sales by Manufacturers
  6. 4.2.1 Global Lenalidomide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lenalidomide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lenalidomide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lenalidomide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lenalidomide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lenalidomide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lenalidomide Manufacturers, Product Type & Application
  13. 4.7 Global Lenalidomide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lenalidomide Market CR5 and HHI
  16. 4.8.2 2025 Lenalidomide Tier 1, Tier 2, and Tier 3
5 Lenalidomide Market by Type
  1. 5.1 Global Lenalidomide Revenue by Type
  2. 5.1.1 Global Lenalidomide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lenalidomide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lenalidomide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lenalidomide Sales by Type
  6. 5.2.1 Global Lenalidomide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lenalidomide Sales by Type (2021-2032) & (K Pcs)
  8. 5.2.3 Global Lenalidomide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lenalidomide Price by Type
6 Lenalidomide Market by Application
  1. 6.1 Global Lenalidomide Revenue by Application
  2. 6.1.1 Global Lenalidomide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lenalidomide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lenalidomide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lenalidomide Sales by Application
  6. 6.2.1 Global Lenalidomide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lenalidomide Sales by Application (2021-2032) & (K Pcs)
  8. 6.2.3 Global Lenalidomide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lenalidomide Price by Application
7 Company Profiles
  1. 7.1 Celgene
  2. 7.1.1 Celgene Company Information
  3. 7.1.2 Celgene Business Overview
  4. 7.1.3 Celgene Lenalidomide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Celgene Lenalidomide Product Portfolio
  6. 7.1.5 Celgene Recent Developments
  7. 7.2 SL Pharma
  8. 7.2.1 SL Pharma Company Information
  9. 7.2.2 SL Pharma Business Overview
  10. 7.2.3 SL Pharma Lenalidomide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 SL Pharma Lenalidomide Product Portfolio
  12. 7.2.5 SL Pharma Recent Developments
8 North America
  1. 8.1 North America Lenalidomide Market Size by Type
  2. 8.1.1 North America Lenalidomide Revenue by Type (2021-2032)
  3. 8.1.2 North America Lenalidomide Sales by Type (2021-2032)
  4. 8.1.3 North America Lenalidomide Price by Type (2021-2032)
  5. 8.2 North America Lenalidomide Market Size by Application
  6. 8.2.1 North America Lenalidomide Revenue by Application (2021-2032)
  7. 8.2.2 North America Lenalidomide Sales by Application (2021-2032)
  8. 8.2.3 North America Lenalidomide Price by Application (2021-2032)
  9. 8.3 North America Lenalidomide Market Size by Country
  10. 8.3.1 North America Lenalidomide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lenalidomide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lenalidomide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lenalidomide Market Size by Type
  2. 9.1.1 Europe Lenalidomide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lenalidomide Sales by Type (2021-2032)
  4. 9.1.3 Europe Lenalidomide Price by Type (2021-2032)
  5. 9.2 Europe Lenalidomide Market Size by Application
  6. 9.2.1 Europe Lenalidomide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lenalidomide Sales by Application (2021-2032)
  8. 9.2.3 Europe Lenalidomide Price by Application (2021-2032)
  9. 9.3 Europe Lenalidomide Market Size by Country
  10. 9.3.1 Europe Lenalidomide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lenalidomide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lenalidomide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lenalidomide Market Size by Type
  2. 10.1.1 China Lenalidomide Revenue by Type (2021-2032)
  3. 10.1.2 China Lenalidomide Sales by Type (2021-2032)
  4. 10.1.3 China Lenalidomide Price by Type (2021-2032)
  5. 10.2 China Lenalidomide Market Size by Application
  6. 10.2.1 China Lenalidomide Revenue by Application (2021-2032)
  7. 10.2.2 China Lenalidomide Sales by Application (2021-2032)
  8. 10.2.3 China Lenalidomide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lenalidomide Market Size by Type
  2. 11.1.1 Asia Lenalidomide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lenalidomide Sales by Type (2021-2032)
  4. 11.1.3 Asia Lenalidomide Price by Type (2021-2032)
  5. 11.2 Asia Lenalidomide Market Size by Application
  6. 11.2.1 Asia Lenalidomide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lenalidomide Sales by Application (2021-2032)
  8. 11.2.3 Asia Lenalidomide Price by Application (2021-2032)
  9. 11.3 Asia Lenalidomide Market Size by Country
  10. 11.3.1 Asia Lenalidomide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lenalidomide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lenalidomide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lenalidomide Market Size by Type
  2. 12.1.1 SAMEA Lenalidomide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lenalidomide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lenalidomide Price by Type (2021-2032)
  5. 12.2 SAMEA Lenalidomide Market Size by Application
  6. 12.2.1 SAMEA Lenalidomide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lenalidomide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lenalidomide Price by Application (2021-2032)
  9. 12.3 SAMEA Lenalidomide Market Size by Country
  10. 12.3.1 SAMEA Lenalidomide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lenalidomide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lenalidomide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lenalidomide Value Chain Analysis
  2. 13.1.1 Lenalidomide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lenalidomide Production Mode & Process
  6. 13.2 Lenalidomide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lenalidomide Distributors
  9. 13.2.3 Lenalidomide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst